Tuesday broker round-up
23rd Mar 2021 13:12
(Sharecast News) - Fevertree: Barclays upgrades to buy with a target price of 2,500p.
Read morePharmacovigilance drives growth at Ergomed
23rd Mar 2021 12:56
(Sharecast News) - Pharmaceutical services company Ergomed reported a 26.5% increase in revenue in its full-year results on Tuesday, to £86.4m.
Read moreSunday share tips: Ergomed, Johnson Matthey
6th Dec 2020 13:02
(Sharecast News) - The Mail on Sunday's Midas column recommended readers 'buy' shares of pharmacovigilance specialist Ergomed.
Read moreErgomed reports on 'excellent' first half
21st Jul 2020 16:26
(Sharecast News) - Specialised pharmaceutical services company Ergomed said on Tuesday that it had an "excellent" first half, with overall growth in revenue driven by continued demand for its services across the integrated business, despite the Covid-19 pandemic.
Read moreErgomed reports decent first quarter
10th Jun 2020 07:56
(Sharecast News) - Specialist pharmaceutical services company Ergomed said on Wednesday that it had a "good" first quarter, with "solid" overall growth in revenue.
Read moreErgomed joins Covid-19 therapy programme
6th Apr 2020 16:11
(Sharecast News) - Specialised pharmaceutical services provider Ergomed announced on Monday that it is providing support for a clinical development programme for 'namilumab', a monoclonal antibody therapy targeting granulocyte-macrophage colony stimulating factor (GM-CSF), for the treatment of patients with rapidly worsening Covid-19 coronavirus symptoms.
Read moreErgomed to check drug safety for US Covid-19 trial
30th Mar 2020 12:19
(Sharecast News) - Ergomed said it would provide drug safety services for a US trial to assess the benefits of a rheumatoid arthritis treatment for patients suffering from severe coronavirus infections.
Read moreErgomed earnings rise as it begins Covid therapy testing
25th Mar 2020 15:05
(Sharecast News) - Pharmaceutical services company Ergomed reported a 26.1% improvement in its revenue to ?68.3m on a comparable basis in its full-year results on Wednesday.
Read moreErgomed confirms involvement in Italian Covid-19 study
18th Mar 2020 09:20
(Sharecast News) - Specialist pharmaceutical services company Ergomed announced on Wednesday the start of a study of 'siltuximab', an interleukin-6 targeted monoclonal antibody, for the treatment of patients with Covid-19 who had developed serious respiratory complications.
Read moreErgomed sees FY earnings beating expectations
29th Jan 2020 11:04
(Sharecast News) - Pharmaceutical industry services provider Ergomed said on Wednesday that it had continued to deliver strong year-on-year top-line growth and now expects full-year underlying earnings to come in ahead of current market expectations.
Read moreErgomed acquires Ashfield Pharmacovigilance from UDG
13th Jan 2020 10:39
(Sharecast News) - Pharmaceutical services provider Ergomed announced the acquisition of Ashfield Pharmacovigilance, a specialist pharmacovigilance services provider based in Cary in the 'Research Triangle' of North Carolina on Monday.
Read moreErgomed names Lewis Cameron as next COO
2nd Dec 2019 08:05
(Sharecast News) - Pharmaceutical industry services provider Ergomed named Lewis Cameron as its next chief operating officer on Monday.
Read moreDirector dealings: Ergomed founder ups stake
25th Jun 2019 15:51
(Sharecast News) - Ergomed revealed on Tuesday that executive chairman Dr Miroslav Reljanovic had acquired a total of 200,000 ordinary shares in the AIM-listed biotechnology firm.
Read moreErgomed names former Chiltern International finance head as CFO
4th Jun 2019 09:07
(Sharecast News) - Pharmaceutical industry services provider Ergomed named Richard Barfield to take over from chief financial officer Stuart Jackson on Tuesday.
Read moreThursday broker round-up
16th May 2019 13:02
(Sharecast News) - Grainger: Numis downgrades to add with a target price of 295p.
Read more